跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 788 条关于
“AAV9-TNNT2-ALPK3”
全部
788
临床试验
140
药物
489
机构
0
资讯
159
29天前
ALPK3 gene therapy reverses severe childhood cardiomyopathy in mouse and human models
上个月
Andelyn Biosciences Partners with Queen's University to Manufacture AAV9-GM2 Gene Therapy for GM2 Gangliosidoses
上个月
Genezen and Raiden Science Foundation Partner to Advance First AAV9 Gene Replacement Therapy for UBA5 Disorder Toward Clinical Trial
9天前
EpilepsyGTx Taps Viralgen's Aava Platform to Manufacture AAV Gene Therapy EPY201 Ahead of First-in-Human Trial
11个月前
JCR Pharmaceuticals' JUST-AAV Platform Achieves 52-Fold Improvement in Muscle Gene Delivery While Reducing Liver Exposure
去年
Dyno Therapeutics Unveils Three AI-Designed AAV Capsids for Enhanced Gene Therapy Delivery
去年
Prevail Therapeutics' PR001 Gene Therapy Trial for Parkinson's Disease Progresses
去年
Coave Therapeutics Unveils coAAV-CSF-01: A Breakthrough Gene Therapy Vector for CNS Diseases
去年
CAP-003 Gene Therapy Shows Promise for Parkinson's Disease with GBA Mutations
3年前
Siren Biotechnology Unveils Promising Preclinical Data for Novel Cancer Treatment Combining AAV Gene Therapy with Cytokine Immunotherapy
第 1 页,共 16 页
上一页
下一页